针对癌症治疗的免疫细胞应激和细胞死亡
Lorenzo Galluzzi1,2,3, Emma Guilbaud4, Darby Schmidt5
1Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA. deadoc80@gmail.com.
Nature reviews. Drug discovery
|April 15, 2024
概括
免疫性细胞死亡 (ICD) 是新的癌症治疗的关键. 克服ICD诱导剂开发的挑战对于有效的抗癌治疗和免疫疗法至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 免疫性细胞死亡 (ICD) 是癌症治疗开发的关键机制.
- 治疗策略旨在诱导ICD以提高免疫疗法的疗效,特别是在感冒瘤中.
- 目前的方法面临挑战,因为癌细胞的复杂性和免疫不可知治疗原则.
研究的目的:
- 突出ICD在新型抗癌治疗开发中的核心作用.
- 确定阻碍开发ICD诱导治疗的障碍.
- 强调需要改进ICD诱导器的发现平台.
主要方法:
- 审查现有的治疗策略,以引起ICD.
- 分析当前癌症细胞生物学和治疗开发的局限性.
- 对ICD诱导器的当前发现平台的评估.
主要成果:
- ICD对于将免疫疗法耐药瘤转化为响应性瘤至关重要.
- 障碍包括癌细胞的复杂性和免疫不可知治疗策略.
- 现有的ICD诱导器发现平台存在重大局限性.
结论:
- 解决癌细胞生物学和治疗原则的复杂性是必不可少的.
- 改进发现平台对于推进基于ICD的癌症疗法至关重要.
- 更清楚地了解细胞死亡途径将有助于设计有效的ICD诱导剂.
相关概念视频
Tumor Immunotherapy
522
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522
Psychoneuroimmunology: Diabetes and Cancer
28
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
28
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Cytotoxic T Cells-mediated Immune Response
904
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
904


